Andrew Hantel.

Andrew Hantel, MD, MPH

Assistant Professor of Medicine, Harvard Medical School
Investigator, Divisions of Hematologic Malignancies and Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute
Member, HMS Center for Bioethics
Dana-Farber Cancer Institute 450 Brookline Avenue, DA-1133 Boston, MA 02215
Harvard Catalyst Profile and Publications

Andrew Hantel, MD, MPH is a health services researcher, hematologic oncologist, and ethics consultant at Dana-Farber Cancer Institute (DFCI) and Harvard Medical School. He received his MD from Loyola University Chicago and his MPH from the Harvard School of Public Health. He completed internal medicine and hematology/oncology training and a fellowship in medical ethics at the University of Chicago and completed a postdoctoral fellowship in cancer population sciences at the Dana-Farber/Harvard Cancer Center. His research program leverages health services methods to address ethical dilemmas in cancer discovery and delivery. Specific interests include patient access to and participation in clinical research, the intersection of climate change with cancer health, and the clinical applications of artificial intelligence. For this, Dr. Hantel has received research funding and awards from the National Institutes of Health, American Society for Clinical Oncology, American Cancer Society, Leukemia and Lymphoma Society, Greenwall Foundation, and Alliance for Clinical Trials in Oncology.